Biontech plans to examine mRNA technology for malaria vaccines
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13156388.ece/ALTERNATES/schema-16_9/20210726-184651-5-1920x1079we.jpg)
German firm Biontech, which in collaboration with Pfizer has developed one of the most widely-used coronavirus vaccines, now plans to create a vaccine against malaria.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EMA currently sees no need for Covid booster jab
For subscribers
Pfizer and Biontech expand study of vaccines for children
For subscribers